{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T03:11:13Z","timestamp":1785899473631,"version":"3.56.0"},"reference-count":24,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T00:00:00Z","timestamp":1721260800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Allergy"],"abstract":"<jats:p>Dysregulation of type 2 (T2) immune response leads to an aberrant inflammatory reaction that constitutes the pathophysiological basis of diseases involving various organs. For this reason, several disorders can coexist in a single patient; however, as different specialists often treat these pathologies, T2 dysregulation, particularly when mild, is not always the first diagnostic suspicion. A breakdown in interdisciplinary communication or the lack of adequate tools to detect these entities can delay diagnosis, and this, together with a lack of coordination, can lead to suboptimal care. In this context, a multidisciplinary group of specialists in pneumology, immunology, allergology, dermatology and otorhinolaryngology compiled a list of the cardinal symptoms reported by patients presenting with T2 inflammation-related diseases: asthma, chronic rhinosinusitis, allergic rhinitis, allergic conjunctivitis, IgE-mediated food allergy, atopic dermatitis, eosinophilic oesophagitis, and NSAID-exacerbated respiratory disease (NERD). Using this information, we propose a simple, patient-friendly questionnaire that can be administered at any level of care to initially screen patients for suspected coexisting T2 diseases and referral to the appropriate specialist.<\/jats:p>","DOI":"10.3389\/falgy.2024.1427279","type":"journal-article","created":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T05:10:14Z","timestamp":1721279414000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Multidisciplinary management of type 2 inflammation diseases using a screening tool"],"prefix":"10.3389","volume":"5","author":[{"given":"Oscar","family":"Palomares","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Cisneros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco Javier","family":"Ortiz de Frutos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Miguel","family":"Villacampa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"D\u00e1vila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,7,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1007\/s40495-017-0114-1","article-title":"Type 2 cytokine responses: regulating immunity to helminth parasites and allergic inflammation","volume":"3","author":"Henry","year":"2017","journal-title":"Curr Pharmacol Rep"},{"key":"B2","doi-asserted-by":"publisher","first-page":"4259","DOI":"10.2147\/jir.S311640","article-title":"Insights into the implications of coexisting type 2 inflammatory diseases","volume":"14","author":"McCormick","year":"2021","journal-title":"J Inflamm Res"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1111\/cea.14029","article-title":"Type 2 immunity-driven diseases: towards a multidisciplinary approach","volume":"51","author":"Hassoun","year":"2021","journal-title":"Clin Exp Allergy"},{"key":"B4","doi-asserted-by":"publisher","first-page":"889221","DOI":"10.3389\/falgy.2022.889221","article-title":"White paper on European patient needs and suggestions on chronic type 2 inflammation of airways and skin by euforea","volume":"3","author":"De Prins","year":"2022","journal-title":"Front Allergy"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1802130","DOI":"10.1183\/13993003.02130-2018","article-title":"Changing prevalence of current asthma and inhaled corticosteroid treatment in the UK: population-based cohort 2006\u20132016","volume":"53","author":"Bloom","year":"2019","journal-title":"Eur Respir J"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2101585","DOI":"10.1183\/13993003.01585-2021","article-title":"European Respiratory society guidelines for the diagnosis of asthma in adults","volume":"60","author":"Louis","year":"2022","journal-title":"Eur Respir J"},{"key":"B7","doi-asserted-by":"publisher","first-page":"5218","DOI":"10.21037\/jtd.2019.11.72","article-title":"Heterogeneity of perception of symptoms in patients with asthma","volume":"11","author":"Ohwada","year":"2019","journal-title":"J Thorac Dis"},{"key":"B8","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.jaci.2020.04.040","article-title":"Type 2 inflammation in chronic rhinosinusitis without nasal polyps: another relevant endotype","volume":"146","author":"Delemarre","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"2812","DOI":"10.1016\/j.jaip.2019.05.009","article-title":"Associations between inflammatory endotypes and clinical presentations in chronic rhinosinusitis","volume":"7","author":"Stevens","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4193\/Rhin20.600","article-title":"European position paper on rhinosinusitis and nasal polyps 2020","volume":"58","author":"Fokkens","year":"2020","journal-title":"Rhinology"},{"key":"B11","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/j.jaci.2017.03.050","article-title":"Allergic rhinitis and its impact on asthma (Aria) guidelines-2016 revision","volume":"140","author":"Bro\u017cek","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"33","DOI":"10.4193\/Rhino.11.071","article-title":"The impact of allergic rhinitis on symptoms, and quality of life using the new criterion of Aria severity classification","volume":"50","author":"Valero","year":"2012","journal-title":"Rhinology"},{"key":"B13","doi-asserted-by":"publisher","first-page":"100482","DOI":"10.1016\/j.waojou.2020.100482","article-title":"Assessment of perception, attitude, and practice of primary care practitioners towards allergic rhinitis practice guidelines: development and validation of a new questionnaire","volume":"13","author":"Abdullah","year":"2020","journal-title":"World Allergy Organ J"},{"key":"B14","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.anai.2019.11.014","article-title":"Icon: diagnosis and management of allergic conjunctivitis","volume":"124","author":"Bielory","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"129","DOI":"10.2500\/aap.2012.33.3525","article-title":"Allergic conjunctivitis: the evolution of therapeutic options","volume":"33","author":"Bielory","year":"2012","journal-title":"Allergy Asthma Proc"},{"key":"B16","first-page":"94","article-title":"Consensus document on allergic conjunctivitis (deca)","volume":"25","author":"S\u00e1nchez-Hern\u00e1ndez","year":"2015","journal-title":"J Investig Allergol Clin Immunol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1007\/s12016-018-8710-3","article-title":"IgE-Mediated food allergy","author":"Anvari","year":"2019","journal-title":"Clin Rev Allergy Immunol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1016\/j.jaad.2022.01.009","article-title":"AAD guidelines: awareness of comorbidities associated with atopic dermatitis in adults","volume":"86","author":"Davis","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jaip.2019.06.044","article-title":"Update on atopic dermatitis: diagnosis, severity assessment, and treatment selection","volume":"8","author":"Fishbein","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B20","doi-asserted-by":"publisher","first-page":"247","DOI":"10.3389\/fmed.2018.00247","article-title":"Eosinophilic esophagitis: review and update","volume":"5","author":"Gomez Torrijos","year":"2018","journal-title":"Front Med (Lausanne)"},{"key":"B21","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jaci.2011.02.040","article-title":"Eosinophilic esophagitis: updated consensus recommendations for children and adults","volume":"128","author":"Liacouras","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.wjorl.2018.08.001","article-title":"Pathogenesis of nsaid-induced reactions in aspirin-exacerbated respiratory disease","volume":"4","author":"Laidlaw","year":"2018","journal-title":"World J Otorhinolaryngol Head Neck Surg"},{"key":"B23","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.jaci.2021.06.018","article-title":"Clinical evaluation and diagnosis of aspirin-exacerbated respiratory disease","volume":"148","author":"Haque","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"100180","DOI":"10.1016\/j.opresp.2022.100180","article-title":"Checklist for the multidisciplinary approach to united airway in patients with chronic rhinosinusitis with nasal polyps (CRSwNP) and asthma","volume":"4","author":"Castillo Vizuete","year":"2022","journal-title":"Open Respir Arch"}],"container-title":["Frontiers in Allergy"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/falgy.2024.1427279\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T05:10:17Z","timestamp":1721279417000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/falgy.2024.1427279\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,18]]},"references-count":24,"alternative-id":["10.3389\/falgy.2024.1427279"],"URL":"https:\/\/doi.org\/10.3389\/falgy.2024.1427279","relation":{},"ISSN":["2673-6101"],"issn-type":[{"value":"2673-6101","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,18]]},"article-number":"1427279"}}